Charles River Laboratorie... (CRL)

NYSE: CRL · Real-Time Price · USD

116.92

-1.70 (-1.43%)

At close: May 01, 2025, 3:59 PM

117.00

0.07%

After-hours: May 01, 2025, 07:28 PM EDT

Charles River Laboratories International Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 28, 2024	Dec 30, 2023	Dec 31, 2022	Dec 25, 2021	Dec 26, 2020	Dec 28, 2019	Dec 29, 2018	Dec 30, 2017	Dec 31, 2016
Cash & Equivalents	194.61M	276.77M	233.91M	241.21M	228.42M	238.01M	195.44M	163.79M	117.63M
Short-Term Investments	n/a	n/a	998K	1.06M	1.02M	941K	885K	28.49M	3.77M
Long-Term Investments	218.35M	243.81M	311.6M	201.35M	221.8M	122.98M	88.59M	71.1M	45.33M
Other Long-Term Assets	278.23M	309.38M	148.28M	151.54M	130.82M	89.64M	55.17M	52.9M	43.1M
Receivables	720.91M	780.38M	752.39M	642.88M	617.74M	514.03M	472.25M	430.02M	364.05M
Inventory	278.54M	380.26M	255.81M	199.15M	185.69M	160.66M	127.89M	114.96M	95.83M
Other Current Assets	209.01M	83.38M	107.58M	97.31M	n/a	300K	300K	n/a	n/a
Total Current Assets	1.4B	1.61B	1.44B	1.27B	1.2B	1.02B	897.84M	826.63M	656.83M
Property-Plant & Equipment	2.02B	2.03B	1.86B	1.58B	1.3B	1.18B	932.88M	781.97M	755.83M
Goodwill & Intangibles	3.57B	3.96B	3.81B	3.77B	2.6B	2.23B	1.86B	1.17B	1.18B
Total Long-Term Assets	6.13B	6.59B	6.16B	5.75B	4.29B	3.67B	2.96B	2.1B	2.05B
Total Assets	7.53B	8.2B	7.6B	7.02B	5.49B	4.69B	3.86B	2.93B	2.71B
Account Payables	140.34M	168.94M	205.91M	198.13M	122.47M	111.5M	66.25M	77.84M	68.48M
Deferred Revenue	248.32M	241.82M	264.26M	219.7M	207.94M	171.81M	145.14M	117.57M	127.73M
Short-Term Debt	n/a	n/a	50.2M	101K	47.2M	35.55M	31.42M	31M	27.31M
Other Current Liabilities	605.44M	431.04M	334.23M	307.01M	259.74M	183.29M	181.18M	92.81M	86.97M
Total Current Liabilities	994.1M	1.06B	1.09B	1.03B	839.75M	710.18M	558.22M	463.5M	429.59M
Long-Term Debt	2.72B	2.65B	2.71B	2.92B	1.9B	1.82B	1.64B	1.11B	1.21B
Other Long-Term Liabilities	195.21M	223.19M	149.03M	-30.69M	185.74M	161.95M	118.65M	166.93M	137.81M
Total Long-Term Liabilities	3.03B	3.48B	3.49B	3.4B	2.51B	2.32B	1.96B	1.4B	1.43B
Total Liabilities	4.02B	4.54B	4.58B	4.43B	3.35B	3.03B	2.52B	1.87B	1.86B
Total Debt	2.72B	3.07B	3.1B	2.92B	2.14B	2B	1.67B	1.15B	1.24B
Common Stock	511K	513K	509K	505K	498K	489K	482K	875K	863K
Retained Earnings	1.81B	1.89B	1.43B	980.75M	625.41M	280.33M	42.1M	288.66M	165.3M
Comprehensive Income	-317.35M	-196.43M	-262.06M	-164.74M	-138.87M	-178.02M	-172.7M	-144.73M	-253.76M
Shareholders Equity	3.46B	3.6B	2.98B	2.53B	2.11B	1.63B	1.32B	1.05B	836.77M
Total Investments	218.35M	243.81M	311.6M	202.41M	222.83M	123.92M	89.48M	99.59M	49.1M